Foreign Filer Report • Nov 12, 2019
Foreign Filer Report
Open in ViewerOpens in native device viewer
_________ false
| ������� �� ��� ��"� | 2 379 |
| BIOLINE RX LTD | |
| Corporation no: 513398750 | 9253 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C001 ( Public ) | Reported via MAGNA: | 12/11/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-110365 | Time of broadcast: 12:50 12:45:48 |
Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onBioLineRx completes report of third quarter 2019 financial results
6-K_Q319_results_isa.pdf
Link to filing on foreign stock exchange (optional): _________
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| 2019-02-109981 | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 29/10/2019 |
| Address: HaMa'ayan 2 , Modi'in 7177871 , Israel Tel: 08-6429100 , Fax: 08-6429101 | |
| E-mail address: [email protected] Company site: www.biolinerx.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Kotler Norman Harold Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company: | |
| Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: [email protected] 1 | |
| Israel |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.